TMCnet News
Research and Markets: China Pharmaceutical Guide 2014 - 9th Edition Out NowDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/5r7gxr/china) has announced the addition of the "China Pharmaceutical Guide 2014 (9th Edition)" report to their offering. Written by veteran pharma industry executives to help guide international players navigate through the complex and turbulent Chinese healthcare business environment, it is the most authoritative reference on China's pharmaceutical and healthcare business. Extensive coverage on China's pharma industry and healthcare sector, structure and market environment, regulatory framework, healthcare provision and financing, disease & drug consumption patterns, pharma sales, marketing & distribution, trends and opportunities, market entry strategies, case studies of successes and failures in six key areas of the Chinese pharma business, and profiles of leading MNC pharma players in China. The 2014 edition has been thoroughly updated with sinificantly expanded coverage in recent editions on more sub-sectors, outsourcing, clinical practices, regulatory updates on healthcare reform and drug policies, additional case studies, and latest market / health data updated through mid-2014. Key Topics Covered: Part I Overview Of The Chinese Economy And Business Part II The Chinese Pharmaceutical Industry And Market Part III Pharmaceutical Regulatory Framework Part IV Healthcare Provision And Financing Part V Disease And Drug Consumption Patterns Part VI Pharmaceutical Sales, Marketing And Distribution In China Part VII Contemporary Trends, Opportunities And Strategic Considerations Part VIII Market Entry Strategies And Execution Part IX Mini Case Studies Part X Company Profiles: Multinational Pharma Companies In China Companies Mentioned
For more information visit http://www.researchandmarkets.com/research/5r7gxr/china |
